pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ajax Therapeutics Inc · news · pharmadog
← back to Ajax Therapeutics Inc
News mentioning Ajax Therapeutics Inc
8
stories
5d
Lilly secures another myelofibrosis option via $1.5B deal for JPM-founded Calytrix
fiercebiotech
Sep 11, 26
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharma dive
Sep 8, 26
Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics
fiercebiotech
Aug 5, 26
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
biospace
Jun 15, 26
Lilly scores early positive data for new JAK drug
biopharma dive
Apr 27, 26
Lilly to buy startup Ajax in bid for a better JAK drug
biopharma dive
Apr 27, 26
STAT+: Astellas retries XLMTM gene therapy after deaths
stat
Apr 27, 26
Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor
endpoints